Stevens Capital Management LP Sage Therapeutics, Inc. Transaction History

Stevens Capital Management LP

  • $703 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 06, 2019
SELL
$81.94 - $139.71 $2.14 Million - $3.66 Million
-26,177 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$138.11 - $169.04 $3.17 Million - $3.88 Million
22,954 Added 712.19%
26,177 $3.7 Million
Q2 2018

Aug 09, 2018
BUY
$140.36 - $175.76 $452,380 - $566,474
3,223 New
3,223 $504,000

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email